# A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

> **NCT03590366** · PHASE2 · COMPLETED · sponsor: **AOBiome LLC** · enrollment: 140 (actual)

## Conditions studied

- Rosacea

## Interventions

- **BIOLOGICAL:** B244
- **BIOLOGICAL:** Vehicle

## Key facts

- **NCT ID:** NCT03590366
- **Lead sponsor:** AOBiome LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-02
- **Primary completion:** 2019-02-11
- **Final completion:** 2019-03-05
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2022-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03590366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03590366, "A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03590366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*